story of the week
CDK4/6 Inhibition in Patients With HR-Positive HER2-Negative, Advanced Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology